During the past decade, Fredericia Sygehus conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Fredericia Sygehus" #1 sponsor was "Ipsen" with 2 trials, followed by "Advanz Pharma" with 1 trials sponsored, "Genzyme, a Sanofi Company" with 1 trials sponsored, "Medtronic Diabetes" with 1 trials sponsored and "Medtronic Diabetes R&D Denmark" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Fredericia Sygehus" #1 collaborator was "Astellas Pharma US, Inc." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Fredericia Sygehus" are "Advanced Prostate Cancer" (1 trials), "Atrial Fibrillation" (1 trials), "Chronic Kidney Disease" (1 trials), "Diabetes Mellitus Type I" (1 trials) and "Diabetes Mellitus Type II" (1 trials). Many other conditions were trialed in "Fredericia Sygehus" in a lesser frequency.

Most popular intervention types in "Fredericia Sygehus" are "Drug" (3 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Calcium acetate (PhosLo® )" (1 trials), "Integrated sensor and infusion set." (1 trials), "Sevelamer Hydrochloride (Renagel®)" (1 trials), "Triptorelin (Decapeptyl®)" (1 trials) and "Vernakalant Injection 20 mg/mL" (1 trials). Other intervention names were less common.

The vast majority of trials in "Fredericia Sygehus" are 4 trials for "All" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Fredericia Sygehus". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Fredericia Sygehus, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Fredericia Sygehus, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".